Article info

Download PDFPDF
Extended report
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Authors

  1. Correspondence to Professor Gabriela Riemekasten, Department of Rheumatology, University Hospital Schleswig-Holstein—Campus Lübeck, Ratzeburger Allee 160, Lübeck 23538, Germany; Gabriela.Riemekasten{at}uksh.de
View Full Text

Citation

von Spee-Mayer C, Siegert E, Abdirama D, et al
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus

Publication history

  • Received April 13, 2015
  • Revised July 30, 2015
  • Accepted August 12, 2015
  • First published August 31, 2015.
Online issue publication 
June 10, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.